H. W. Reesink

Papers

Total Citations

H-Index

About

Dr. H. W. Reesink is a leading figure in transfusion medicine and blood safety, with a career dedicated to safeguarding blood supplies against emerging infectious threats. His research focuses on the epidemiology of transfusion-transmissible viruses, including West Nile virus (WNV), hepatitis E virus (HEV), and other pathogens that pose risks to blood recipients. A key contribution is his pioneering work assessing the prevalence of WNV among Dutch blood donors, demonstrating no evidence of infection in a 2006 study (8 citations) and establishing critical baseline data for European blood safety protocols. Beyond this, Reesink has been instrumental in evaluating donor screening strategies, pathogen inactivation technologies, and risk mitigation measures that have shaped international guidelines. His impact is reflected in numerous collaborative studies and policy recommendations that balance safety with blood supply sustainability. Notably, his research has advanced understanding of HEV transmission through transfusion, leading to improved donor screening in several countries. Dr. Reesink’s work remains essential for clinicians, blood bank professionals, and researchers striving to protect patients from emerging infectious risks.